Peptonic Medical is a pharmaceutical company. Currently, the focus is on the treatment of female vaginal atrophy. The company offers a treatment free from oestrogen, where the products contain the oxytocin hormone. A large part of the projects is carried out in collaboration with other industry players. The main business is found on the Nordic market. The company is based in Bromma.

Quotes for PEPTONIC Medical AB

Right Now

+/-
0.0002
%
4,55%
Latest
0.0046
High
0.0046
Low
0.0042
Volume
9 599 969
Turnover (SEK)
42 843
Market Value (MSEK)
26,5
Time (Latest trade)
2024-12-09 16:40

Board

CEO

  • Anna Linton

Chairperson of the Board

  • Anders Blom

Board

  • Daniel Rudeklint
  • Kristina Ingvar
  • Tarek Schoeb

Videos

Largest Owners

Name Capital % Votes % Date
Maida Vale Capital AB 25,60 25,60 2024-09-26
Nordnet Pensionsförsäkring 8,36 8,36 2024-09-26
Heli Kurjanen 3,71 3,71 2023-12-31
Quartier Latin AB 3,08 3,08 2024-09-26
Avanza Pension 2,97 2,97 2024-09-26
Vidarstiftelsen 2,95 2,95 2024-09-26
Mika Kurjanen 1,93 1,93 2023-12-31
Henrik Hahn 1,06 1,06 2024-09-26
Petter Eriksson 0,98 0,98 2024-09-26
Tarek Nabil Shoeb 0,76 0,76 2024-09-26
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

*Compiled data from Millistream